Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Atorvastatin Reduces Macrophage Accumulation in Atherosclerotic Plaques A Comparison of a Nonstatin-Based Regimen in Patients Undergoing Carotid Endarterectomy
Atorvastatin prevents age-related and amyloid-beta-induced microglial activation by blocking interferon-gamma release from natural killer cells in the brain
Atorvastatin for the Treatment of Plaque-Type Psoriasis
Atorvastatin increases exercise leg blood flow in healthy adults
Atorvastatin Prevents Ischemic Limb Loss in Type 2 Diabetes: Role of p53
Atorvastatin ameliorates LPS-induced inflammatory response by autophagy via AKT/mTOR signaling pathway
Atorvastatin treatment in a dog preclinical model of Alzheimer%26apos;s disease leads to up-regulation of haem oxygenase-1 and is associated with reduced oxidative stress in brain
Atorvastatin modulates constitutive and lipopolysaccharide induced IL-6 secretion in precursors of human skeletal muscle
Atorvastatin and Simvastatin, but not Pravastatin, Up-regulate LPS-Induced MMP-9 Expression in Macrophages by Regulating Phosphorylation of ERK and CREB
Atorvastatin and pitavastatin reduce senile plaques and inflammatory responses in a mouse model of Alzheimer%26apos;s disease
Atorvastatin does not Affect Ischaemia-Induced Phosphatidylserine Exposition in Humans in-vivo
Atorvastatin Sensitises Vascular Smooth Muscle Cells, but not Endothelial Cells, to TNF-alpha-induced Cell Death
Atorvastatin, Valsartan, and N-Acetylcysteine Prevent Cardiac Hypertrophy and Overexpression of Myocardin in Pressure-Overloaded Rat Heart
Atorvastatin Delays Murine Platelet Activation In Vivo Even in the Absence of Endothelial NO Synthase
Atorvastatin Modulates Regulatory T Cells and Attenuates Cerebral Damage in a Model of Transient Middle Cerebral Artery Occlusion in Rats
Atorvastatin activates autophagy and promotes neurological function recovery after spinal cord injury
Atorvastatin-Medicated Dentifrice Significantly Inhibits CD4+T Cell Proliferation: In vitro Pilot Study
Atorvastatin Use Associated With Acute Pancreatitis A Case-Control Study in Taiwan
Atorvastatin downregulates co-inhibitory receptor expression by targeting Ras-activated mTOR signalling
Atorvastatin as a Promising Crystallization Inhibitor of Amorphous Probucol: Dielectric Studies at Ambient and Elevated Pressure
Atorvastatin inhibits PDGF-BB induced vascular smooth muscle cells proliferation and migration in cerebrovascular diseases
Atorvastatin ameliorates cardiac fibrosis and improves left ventricular diastolic function in hypertensive diastolic heart failure model rats
Atorvastatin Prevents Early Oxidative Events and Modulates Inflammatory Mediators in the Striatum Following Intranasal 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Administration in Rats
Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks
Atorvastatin in nano-particulate formulation abates muscle and liver affliction when coalesced with coenzyme Q10 and/or vitamin E in hyperlipidemic rats
Atorvastatin exerts inhibitory effect on endothelial senescence in hyperlipidemic rats through a mechanism involving down-regulation of miR-21-5p/203a-3p
Atorvastatin impaired glucose metabolism in C2C12 cells partly via inhibiting cholesterol-dependent glucose transporter 4 translocation
Atorvastatin Attenuates Metabolic Remodeling in Ischemic Myocardium through the Downregulation of UCP2 Expression
Atorvastatin attenuates experimental contrast-induced acute kidney injury: a role for TLR4/MyD88 signaling pathway
Atorvastatin Calcium Inhibits PDGF-beta beta-Induced Proliferation and Migration of VSMCs Through the G0/G1 Cell Cycle Arrest and Suppression of Activated PDGFR beta-PI3K-Akt Signaling Cascade
Atorvastatin inhibits osteoclastogenesis and arrests tooth movement
Atorvastatin protects mouse brain against cerebral ischemia/reperfusion injury via down-regulating MMP-2 and MMP-9 expression
Atorvastatin Reduces the Survival of Candida albicans-Infected BALB/c Mice
Atorvastatin and metformin administration modulates experimental Trichinella spiralis infection
Atorvastatin Inhibits Inflammatory Response, Attenuates Lipid Deposition, and Improves the Stability of Vulnerable Atherosclerotic Plaques by Modulating Autophagy
Atorvastatin Inhibits the HIF1 alpha-PPAR Axis, Which Is Essential for Maintaining the Function of Human Induced Pluripotent Stem Cells
Atorvastatin treatment softens human red blood cells: an optical tweezers study
Atorvastatin improves plaque stability in diabetic atherosclerosis through the RAGE pathway
Atorvastatin pretreatment attenuates kainic acid-induced hippocampal neuronal death via regulation of lipocalin-2-associated neuroinflammation
Atorvastatin inhibits osteoclast differentiation by suppressing NF-kappa B and MAPK signaling during IL-1 beta-induced osteoclastogenesis
Atorvastatin prevents glomerular extracellular matrix formation by interfering with the PKC signaling pathway
Atorvastatin enhances bone marrow endothelial cell function in corticosteroid-resistant immune thrombocytopenia patients
Atorvastatin Protects Kidney from Remote Reperfusion Injury
Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial
Atorvastatin Attenuates Cognitive Deficits and Neuroinflammation Induced by A beta(1-42) Involving Modulation of TLR4/TRAF6/NF-kappa B Pathway
Atorvastatin Attenuates Myocardial Hypertrophy in Spontaneously Hypertensive Rats via the C/EBP beta/PGC-1 alpha/UCP3 Pathway
Atorvastatin: In-Vivo Synergy with Metronidazole as Anti-Blastocystis Therapy
Atorvastatin Attenuates Myocardial Hypertrophy Induced by Chronic Intermittent Hypoxia In Vitro Partly through miR-31/PKC epsilon Pathway
Atorvastatin and diacerein reduce insulin resistance and increase disease tolerance in rats with sepsis
Atorvastatin and insulin equally mitigate brain pathology in diabetic rats
Atorvastatin induces MicroRNA-145 expression in HEPG2 cells via regulation of the PI3K/AKT signalling pathway
Atorvastatin Promotes Cytotoxicity and Reduces Migration and Proliferation of Human A172 Glioma Cells
Atorvastatin protects the proliferative ability of human umbilical vein endothelial cells inhibited by angiotensin II by changing mitochondrial energy metabolism
Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitro (vol 7, pg 2478, 2017)
Atorvastatin Downregulates In Vitro Methyl Methanesulfonate and Cyclophosphamide Alkylation-Mediated Cellular and DNA Injuries
Atorvastatin ameliorates early brain injury through inhibition of apoptosis and ER stress in a rat model of subarachnoid hemorrhage
Atorvastatin modulates drug transporters and ameliorates nicotine-induced testicular toxicity
Atorvastatin reduces plasminogen activator inhibitor-1 expression in adipose tissue of atherosclerotic rabbits
Atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic stroke
Atorvastatin ameliorates the contractile dysfunction of the aorta induced by organ culture.
Atorvastatin attenuates paraquat poisoning-induced epithelial-mesenchymal transition via downregulating hypoxia-inducible factor-1 alpha
Atorvastatin upregulates apolipoprotein M expression via attenuating LXR alpha expression in hyperlipidemic apoE-deficient mice
Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitro
Atorvastatin-loaded micelles with bone-targeted ligand for the treatment of osteoporosis
Atorvastatin enhances endothelial adherens junctions through promoting VE-PTP gene transcription and reducing VE-cadherin-Y731 phosphorylation.
Atorvastatin Pretreatment Attenuates Ischemic Brain Edema by Suppressing Aquaporin 4
Atorvastatin and Caffeine in Combination Regulates Apoptosis, Migration, Invasion and Tumorspheres of Prostate Cancer Cells
Atorvastatin might resist tobacco smoking-induced endothelial inflammation through the inhibition of NF-κB signal pathway
Atorvastatin protects cardiac progenitor cells from hypoxia-induced cell growth inhibition via MEG3/miR-22/HMGB1 pathway
Atorvastatin induces autophagy in MDA-MB-231 breast cancer cells
Atorvastatin calcium inclusion complexation with polysaccharide arabinogalactan and saponin disodium glycyrrhizate for increasing of solubility and bioavailability
Atorvastatin combined with poly-unsaturated fatty acid confers better improvement of dyslipidemia and endothelium function
Atorvastatin downregulates HSP22 expression in an atherosclerotic model in vitro and in vivo.
Atosiban and nifedipine in the suppression of pre-term labour: A comparative study
Atosiban versus betamimetics in the treatment of preterm labour in Italy: clinical and economic importance of side-effects
Atosiban and non-cardiogenic pulmonary oedema
Atovaquone-proguanil: Report from the CDC expert meeting on malaria chemoprophylaxis (II)
Atovaquone-statine "Double-Drugs" with high antiplasmodial activity
Atovaquone-proguanil in the treatment of imported uncomplicated Plasmodium falciparum malaria: a prospective observational study of 553 cases
Atovaquone Tolerance in Plasmodium falciparum Parasites Selected for High-Level Resistance to a Dihydroorotate Dehydrogenase Inhibitor
Atovaquone and ELQ-300 Combination Therapy as a Novel Dual-Site Cytochrome bc(1) Inhibition Strategy for Malaria
Atovaquone ameliorate gastrointestinal Toxoplasmosis complications in a pregnancy model
Atovaquone-Proguanil Use in Early Pregnancy and the Risk of Birth Defects